Genetic variability in DNA repair proteins in age-related macular degeneration

International Journal of Molecular Sciences

Volumn 13, Issue 10, 2012, Pages 13378-13397

  Blasiak, Janusz ^a   Synowiec, Ewelina ^a   Salminen, Antero ^b,c   Kaarniranta, Kai ^b,c  

^a UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Age related macular degeneration; AMD; DNA repair; Genetic polymorphism

Indexed keywords

DEOXYRIBONUCLEOPROTEIN; DNA GLYCOSYLASE MUTY; DNA GLYCOSYLTRANSFERASE; EXCISION REPAIR CROSS COMPLEMENTING RODENT REPAIR DEFICIENCY COMPLEMENTATION GROUP 6; HOGG1 PROTEIN; SMUG1 PROTEIN; UNCLASSIFIED DRUG; UNG PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN; DNA BINDING PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; URACIL DNA GLYCOSIDASE;

ALLELE; DNA REPAIR; ERCC6 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOGG1 GENE; HUMAN; MUTYH GENE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RNA DEGRADATION; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; UNG GENE; XPD GENE; XRCC1 GENE; GENETIC POLYMORPHISM; GENETICS; MACULAR DEGENERATION; METABOLISM; PATHOLOGY;

DNA GLYCOSYLASES; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; MACULAR DEGENERATION; POLYMORPHISM, GENETIC; URACIL-DNA GLYCOSIDASE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84870766006     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131013378     Document Type: Review

References (107)

1. Khandhadia, S.; Cherry, J.; Lotery, A.J. Age-related macular degeneration. Adv. Exp. Med. Biol. 2012, 724, 15-36.
2. Hardy, J. Genetic analysis of pathways to Parkinson disease. Neuron 2010, 68, 201-206.
3. Ding, X.; Patel, M.; Chan, C.C. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res. 2009, 28, 1-18.
4. Tong, Y.; Liao, J.; Zhang, Y.; Zhou, J.; Zhang, H.; Mao, M. LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis. Mol. Vis. 2010, 16, 1958-1981.
5. Shields, P.G.; Harris, C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 2000, 18, 2309-2315.
6. Naccarati, A.; Pardini, B.; Hemminki, K.; Vodicka, P. Sporadic colorectal cancer and individual susceptibility: A review of the association studies investigatingthe role of DNA repair genetic polymorphisms. Mutat. Res. 2007, 635, 118-145.
7. Ricceri, F.; Matullo, G.; Vineis, P. Is there evidence of involvement of DNA repair polymorphisms in human cancer. Mutat. Res. 2011, doi:10.1016/j.mrfmmm.2011.07.013.
8. Vineis, P.; Manuguerra, M.; Kavvoura, F.K.; Guarrera, S.; Allione, A.; Rosa, F.; di Gregorio, A.; Polidoro, S.; Saletta, F.; Ioannidis, J.P.; et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J. Natl. Cancer Inst. 2009, 101, 24-36.
9. Han, L.; Mao, W.; Yu, K. X-ray repair cross-complementing protein 1 (XRCC1) deficiency enhances class switch recombination and is permissive for alternative end joining. Proc. Natl. Acad. Sci. USA 2012, 109, 4604-4608.
10. Campalans, A.; Marsin, S.; Nakabeppu, Y.; O'connor, T.R.; Boiteux, S.; Radicella, J.P. XRCC1 interactions with multiple DNA glycosylases: A model for its recruitment to base excision repair. DNA Repair 2005, 4, 826-835.
11. Lehmann, A.R. The xeroderma pigmentosum group D (XPD) gene: One gene, two functions, three diseases. Genes Dev. 2001, 15, 15-23.
12. Licht, C.L.; Stevnsner, T.; Bohr, V.A. Cockayne syndrome group B cellular and biochemical functions. Am. J. Hum. Genet. 2003, 73, 1217-1239.
13. Troelstra, C.; Hesen, W.; Bootsma, D.; Hoeijmakers, J.H. Structure and expression of the excision repair gene ERCC6, involved in the human disorder Cockayne's syndrome group B. Nucleic Acids Res. 1993, 21, 419-426.
14. Ishida, T.; Hippo, Y.; Nakahori, Y.; Matsushita, I.; Kodama, T.; Nishimura, S.; Aburatani, H. Structure and chromosome location of human OGG1. Cytogenet. Cell Genet. 1999, 85, 232-236.
15. Hashiguchi, K.; Stuart, J.A.; de Souza-Pinto, N.C.; Bohr, V.A. The C-terminal alpha-O-helix of human Ogg1 is essential for 8-oxoguanine DNA glycosylase activity: The mitochondrial beta-Ogg1 lacks this domain and does not have glycosylase activity. Nucleic Acids Res. 2004, 32, 5596-5608.
16. Takao, M.; Zhang, Q.M.; Yonei, S.; Yasui, A. Differential subcellular localization of human MutY homolog (hMYH) and the functional activity of adenine: 8-Oxoguanine DNA glycosylase. Nucleic Acids Res. 1999, 27, 3638-3644.
17. Masaoka, A.; Matsubara, M.; Hasegawa, R.; Tanaka, T.; Kurisu, S.; Terato, H.; Ohyama, Y.; Karino, N.; Matsuda, A.; Ide, H. Mammalian 5-formyluracil-DNA glycosylase. 2. Role of SMUG1 uracil-DNA glycosylase in repair of 5-formyluracil and other oxidized and deaminated base lesions. Biochemistry 2003, 42, 5003-5012.
18. Krokan, H.E.; Otterlei, M.; Nilsen, H.; Kavli, B.; Skorpen, F.; Andersen, S.; Skjelbred, C.; Akbari, M.; Aas, P.A.; Slupphaug, G. Properties and functions of human uracil-DNA glycosylase from the UNG gene. Prog. Nucleic Acid Res. Mol. Biol. 2001, 68, 365-386.
19. Xue, H.; Ni, P.; Lin, B.; Xu, H.; Huang, G. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. Am. J. Epidemiol. 2011, 173, 363-375.
20. Yin, G.; Morita, M.; Ohnaka, K.; Toyomura, K.; Hamajima, N.; Mizoue, T.; Ueki, T.; Tanaka, M.; Kakeji, Y.; Maehara, Y.; et al. Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan. J. Epidemiol. 2012, 22, 64-71.
21. Zhang, H.; Li, W.; Franklin, M.J.; Dudek, A.Z. Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: A meta-analysis. Anticancer Res. 2011, 31, 3945-3952.
22. Goode, E.L.; Ulrich, C.M.; Potter, J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomark. Prev. 2002, 11, 1513-1530.
23. Lee, J.M.; Lee, Y.C.; Yang, S.Y.; Yang, P.W.; Luh, S.P.; Lee, C.J.; Chen, C.J.; Wu, M.T. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int. J. Cancer 2001, 95, 240-246.
24. Ratnasinghe, D.; Yao, S.X.; Tangrea, J.A.; Qiao, Y.L.; Andersen, M.R.; Barrett, M.J.; Giffen, C.A.; Erozan, Y.; Tockman, M.S.; Taylor, P.R. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol. Biomark. Prev. 2001, 10, 119-123.
25. Stern, M.C.; Umbach, D.M.; van Gils, C.H.; Lunn, R.M.; Taylor, J.A. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol. Biomark. Prev. 2001, 10, 125-131.
26. Duell, E.J.; Millikan, R.C.; Pittman, G.S.; Winkel, S.; Lunn, R.M.; Tse, C.K.; Eaton, A.; Mohrenweiser, H.W.; Newman, B.; Bell, D.A. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol. Biomark. Prev. 2001, 10, 217-222.
27. Johnson, A.B.; Barton, M.C. Hypoxia-induced and stress-specific changes in chromatin structure and function. Mutat. Res. 2007, 618, 149-162.
28. Görgün, E.; Güven, M.; Unal, M.; Batar, B.; Güven, G.S.; Yenerel, M.; Tatlipinar, S.; Seven, M.; Yüksel, A. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2010, 51, 4732-4737.
29. Clarkson, S.G.; Wood, R.D. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: An appraisal. DNA Repair 2005, 4, 1068-1074.
30. Liao, S.G.; Liu, L.; Wang, Y.; Zhang, Y.Y.; Wang, Y.J. XPD Asp312Asn polymorphism is a risk factor for prostate cancer. J. Cancer Res. Clin. Oncol. 2012, doi:10.1007/s00432-012-1246-7.
31. Yuan, H.; Niu, Y.M.; Wang, R.X.; Li, H.Z.; Chen, N. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: A meta-analysis. Genet. Mol. Res. 2011, 10, 3356-3364.
32. Wang, Y.H.; Yeh, S.D.; Shen, K.H.; Shen, C.H.; Tung, M.C.; Liu, C.T.; Chiou, H.Y. Association of hOGG1 and XPD polymorphisms with urothelial carcinoma in Taiwan. Anticancer Res. 2011, 31, 3939-3944.
33. Zhan, P.; Wang, Q.; Wei, S.Z.; Wang, J.; Qian, Q.; Yu, L.K.; Song, Y. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: A meta-analysis involving 22 case-control studies. J. Thorac. Oncol. 2010, 5, 1337-1345.
34. Dybdahl, M.; Vogel, U.; Frentz, G.; Wallin, H.; Nexo, B.A. Polymorphisms in the DNA repair gene XPD: Correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomark. Prev. 1999, 8, 77-81.
35. Vogel, U.; Hedayati, M.; Dybdahl, M.; Grossman, L.; Nexo, B.A. Polymorphisms of the DNA repair gene XPD: Correlations with risk of basal cell carcinoma revisited. Carcinogenesis 2001, 22, 899-904.
36. Vogel, U.; Olsen, A.; Wallin, H.; Overvad, K.; Tjønneland, A.; Nexø, B.A. Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50. Cancer Detect. Prev. 2005, 29, 209-214.
37. Jiang, Z.; Li, C.; Xu, Y.; Cai, S.; Wang, X. Associations between XPD polymorphisms and risk of breast cancer: A meta-analysis. Breast Cancer Res. Treat. 2010, 123, 203-212.
38. Pabalan, N.; Francisco-Pabalan, O.; Sung, L.; Jarjanazi, H.; Ozcelik, H. Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer. Breast Cancer Res. Treat. 2010, 124, 531-541.
39. Hu, Y.Y.; Yuan, H.; Jiang, G.B.; Chen, N.; Wen, L.; Leng, W.D.; Zeng, X.T.; Niu, Y.M.;Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: A meta-analysis based on 7,122 subjects. PLoS One 2012, 7, e35220.
40. Zhang, Y.; Ding, D.; Wang, X.; Zhu, Z.; Huang, M.; He, X. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: A meta-analysis of case-control studies. Int. J. Colorectal Dis. 2011, 26, 1257-1264.
41. Christiansen, M.; Stevnsner, T.; Modin, C.; Martensen, P.M.; Brosh, R.M.; Bohr, V.A. Functional consequences of mutations in the conserved SF2 motifs and post-translational phosphorylation of the CSB protein. Nucleic Acids Res. 2003, 31, 963-973.
42. Stevnsner, T; Muftuoglu, M; Aamann, M.D.; Bohr, V.A. The role of Cockayne Syndrome group B (CSB) protein in base excision repair and aging. Mech. Ageing Dev. 2008, 129, 441-448.
43. Laine, J.P.; Egly, J.M. Initiation of DNA repair mediated by a stalled RNA polymerase IIo. EMBO J. 2006, 2, 387-397.
44. Tuo, J.; Jaruga, P.; Rodriguez, H.; Bohr, V.A.; Dizdaroglu, M. Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress. FASEB J. 2003, 17, 668-674.
45. Stevnsner, T.; Nyaga, S.; de Souza-Pinto N.C.; van der Horst, G.T.; Gorgels, T.G.; Hogue, B.A.; Thorslund, T.; Bohr, V.A. Mitochondrial repair of 8-oxoguanine is deficient in Cockayne syndrome group B. Oncogene 2002, 21, 8675-8682.
46. Lin, Z.; Zhang, X.; Tuo, J.; Guo, Y.; Green, B.; Chan, C.C.; Tan, W.; Huang, Y.; Ling, W.; Kadlubar, F.F.; Lin, D.; Ning, B. A Variant of the Cockayne Syndrome B Gene ERCC6 Confers Risk of Lung Cancer. Hum. Mutat. 2008, 29, 113-122.
47. Berntsson, S.G.; Wibom, C.; Sjöström, S.; Henriksson, R.; Brännström, T.; Broholm, H.; Johansson, C.; Fleming, S.J.; McKinney, P.A.; Bethke, L.; et al. Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomas. J. Neurooncol. 2011, 105, 531-538.
48. Chang, C.H.; Chiu, C.F.; Wang, H.C.; Wu, H.C.; Tsai, R.Y.; Tsai, C.W.; Wang, R.F.; Wang, C.H.; Tsou, Y.A.; Bau, D.T. Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res. 2009, 29, 5121-5124.
49. Ma, H.; Hu, Z.; Wang, H.; Jin, G.; Wang, Y.; Sun, W.; Chen, D.; Tian, T.; Jin, L.; Wei, Q.; et al. ERCC6/CSB gene polymorphisms and lung cancer risk. Cancer Lett. 2009, 273, 172-176.
50. Chiu, C.F.; Tsai, M.H.; Tseng, H.C.; Wang, C.L.; Tsai, F.J.; Lin, C.C.; Bau, D.T. A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol. 2008, 44, 582-586.
51. Tuo, J.; Ning, B.; Bojanowski, C.M.; Lin, Z.N.; Ross, R.J.; Reed, G.F.; Shen, D.; Jiao, X., Zhou, M.; Chew, E.Y.; et al. Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. Proc. Natl. Acad. Sci. USA 2006, 103, 9256-9261.
52. Klein, R.J.; Zeiss, C.; Chew, E.Y.; Tsai, J.Y.; Sackler, R.S.; Haynes, C.; Henning, A.K.; Sangiovanni, J.P.; Mane, S.M.; Mayne, S.T. Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science 2005, 308, 385-389.
53. Baas, D.C.; Despriet, D.D.; Gorgels, T.G.; Bergeron-Sawitzke, J.; Uitterlinden, A.G.; Hofman, A.; van Duijn, C.M.; Merriam, J.E.; Smith, R.T.; Barile, G.R.; et al. The ERCC6 gene and age-related macular degeneration. PLoS One 2010, 5, e13786.
54. Chen, W.; Stambolian, D.; Edwards, A.O.; Branham, K.E.; Othman, M. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2010, 107, 7401-7406.
55. Conrad, D.F.; Pinto, D.; Redon, R. Origins and functional impact of copy number variation in the human genome. Nature 2009, 464, 704-712.
56. Fanciulli, M.; Petretto, E.; Aitman, T.J. Gene copy number variation and common human disease. Clin. Genet. 2010, 77, 201-213.
57. Liu, M.M.; Agrón, E.; Chew, E.; Meyerle, C.; Ferris, F.L.; Chan, C.C.; Tuo, J. Copy number variations in candidate genes in neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52, 3129-3135.
58. Chevillard, S.; Radicella, J.P.; Levalois, C.; Lebeau, J.; Poupon, M.F.; Oudard, S.; Dutrillaux, B.; Boiteux, S. Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene 1998, 16, 3083-3086.
59. Huang, X.X.; Scolyer, R.A.; Abubakar, A.; Halliday, G.M. Human 8-oxoguanine-DNA glycosylase-1 is downregulated in human basal cell carcinoma. Mol. Genet. Metab. 2012, 106, 127-130.
60. Choi, J.Y.; Hamajima, N.; Tajima, K.; Yoo, K.Y.; Yoon, K.S.; Park, S.K.; Kim, S.U.; Lee, K.M.; Noh, D.Y.; Ahn, S.H.; et al. hOGG1 Ser326Cys polymorphism and breast cancer risk among Asian women. Breast Cancer Res. Treat. 2003, 79, 59-62.
61. Hamajima, N.; Takezaki, T.; Tajima, K. Allele Frequencies of 25 Polymorphisms Pertaining to Cancer Risk for Japanese, Koreans and Chinese. Asian Pac. J. Cancer Prev. 2002, 3, 197-206.
62. Takezaki, T.; Gao, C.M.; Wu, J.Z.; Li, Z.Y.; Wang, J.D.; Ding, J.H.; Liu, Y.T.; Hu, X.; Xu, T.L.; Tajima, K.; et al. hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int. J. Cancer 2002, 99, 624-627.
63. Hung, R.J.; Hall, J.; Brennan, P.; Boffetta, P. Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am. J. Epidemiol. 2005, 162, 925-942.
64. Weiss, J.M.; Goode, E.L.; Ladiges, W.C.; Ulrich, C.M. Polymorphic variation in hOGG1 and risk of cancer: A review of the functional and epidemiologic literature. Mol. Carcinog. 2005, 42, 127-141.
65. Wang, A.L.; Lukas, T.J.; Yuan, M.; Neufeld, A.H. Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid. Mol. Vis. 2008, 14, 644-651.
66. Bojanowski, C.M.; Tuo, J.; Vhew, E.Y.; Csaky, K.G.; Chan, C.C. Analysis of hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration. Trans. Am. Ophthalmol. Soc. 2005, 103, 37-44.
67. Synowiec, E.; Blasiak, J.; Zaras, M.; Szaflik, J.; Szaflik, J.P. Association between polymorphisms of the DNA base excision repair genes MUTYH and hOGG1 and age-related macular degeneration. Exp. Eye Res. 2012, 98, 58-66.
68. Boldogh, I.; Milligan, D.; Lee, M.S.; Bassett, H.; Lloyd, R.S.; McCullough, A.K. hMYH cell cycle-dependent expression, subcellular localization and association with replication foci: Evidence suggesting replication-coupled repair of adenine: 8-Oxoguanine mispairs. Nucleic Acids Res. 2001, 29, 2802-2809.
69. Gu, Y.; Parker, A.; Wilson, T.M.; Bai, H.; Chang, D.Y.; Lu, A.L. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J. Biol. Chem. 2002, 277, 11135-11142.
70. Shinmura, K.; Yokota, J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid. Redox Signal. 2001, 3, 597-609.
71. Ali, M.; Kim, H.; Cleary, S.; Cupples, C.; Gallinger, S.; Bristow, R. Characterization of mutant MUTYH proteins associated with familial colorectal cancer. Gastroenterology 2008, 135, 499-507.
72. Kasahara, M.; Osawa, K.; Yoshida, K.; Miyaishi, A.; Osawa, Y.; Inoue, N.; Tsutou, A.; Tabuchi, Y.; Tanaka, K.; Yamamoto, M.; et al. Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. J. Exp. Clin. Cancer Res. 2008, 27, 49.
73. Tao, H.; Shinmura, K.; Suzuki, M.; Kono, S.; Mibu, R.; Tanaka, M.; Kakeji, Y.; Maehara, Y.; Okamura, T.; Ikejiri, K.; et al. Association between genetic polymorphisms of the base excision repair gene MUTYH and increased colorectal cancer risk in a Japanese population. Cancer Sci. 2008, 99, 355-360.
74. Miyaishi, A.; Osawa, K.; Osawa, Y.; Inoue, N.; Yoshida, K.; Kasahara, M.; Tsutou, A.; Tabuchi, Y.; Sakamoto, K.; Tsubota, N.; et al. MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J. Exp. Clin. Cancer Res. 2009, 28, 10.
75. Krokan, H.E.; Drabløs, F.; Slupphaug, G. Uracil in DNA-Occurrence, consequences and repair. Oncogene 2002, 21, 8935-8948.
76. Faure, H.; Mousseau, M.; Cadet, J.; Guimier, C.; Tripier, M.; Hida, H.; Favier, A. Urine 8-oxo-7,8-dihydro-2-deoxyguanosine vs. 5-(hydroxymethyl) uracil as DNA oxidation marker in adriamycin-treated patients. Free Radic. Res. 1998, 28, 377-382.
77. Boorstein, R.J.; Cummings, A., Jr.; Marenstein, D.R.; Chan, M.K.; Ma, Y.; Neubert, T.A.; Brown, S.M.; Teebor, G.W. Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. J. Biol. Chem. 2001, 276, 41991-41997.
78. Kavli, B.; Andersen, S.; Otterlei, M.; Liabakk, N.B.; Imai, K.; Fischer, A.; Durandy, A.; Krokan, H.E.; Slupphaug, G. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J. Exp. Med. 2005, 201, 2011-2021.
79. Synowiec, E.; Wysokinski, D.; Zaraś, M.; Kołodziejska, U.; Stoczynska, E.; Janik, K.; Szaflik, J.; Blasiak, J.; Szaflik, J.P. Association between polymorphism of the DNA repair SMUG1 and UNG genes and age-related macular degeneration. Retina 2012, submitted for publication.
80. Haug, T.; Skorpen, F.; Aas, P.A.; Malm, V.; Skjelbred, C.; Krokan, H.E. Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase. Nucleic Acids Res. 1998, 26, 1449-1457.
81. Nilsen, H.; Otterlei, M.; Haug, T.; Solum, K.; Nagelhus, T.A.; Skorpen, F.; Krokan, H.E. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 1997, 25, 750-755.
82. Kavli, B.; Sundheim, O.; Akbari, M.; Otterlei, M.; Nilsen, H.; Skorpen, F.; Aas, P.A.; Hagen, L.; Krokan, H.E.; Slupphaug, G. hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup. J. Biol. Chem. 2002, 277, 39926-39936.
83. Sousa, M.M.; Krokan, H.E.; Slupphaug, G. DNA-uracil and human pathology. Mol. Aspects Med. 2007, 28, 276-306.
84. Ginsberg, G.; Angle, K.; Guyton, K.; Sonawane, B. Polymorphism in the DNA repair enzyme XRCC1: Utility of current database and implications for human health risk assessment. Mutat. Res. 2011, 727, 1-15.
85. Laczmanska, I.; Gil, J.; Karpinski, P.; Stembalska, A.; Kozlowska, J.; Busza, H.; Trusewicz, A.; Pesz, K.; Ramsey, D.; Schlade-Bartusiak K.; et al. Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE. Environ. Mol. Mutagen. 2006, 47, 666-673.
86. Tuimala, J.; Szekely, G.; Gundy, S.; Hirvonen, A.; Norppa, H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: Role in mutagen sensitivity. Carcinogenesis 2002, 23, 1003-1008.
87. Li, Y.; Marion, M.J.; Zipprich, J.; Freyer, G.; Santella, R.M.; Kanki, C.; Brandt-Rauf, P.W. The role of XRCC1 polymorphisms in base excision repair of etheno-DNA adducts in French vinyl chloride workers. Int. J. Occup. Med. Environ. Health 2006, 19, 45-52.
88. Slyskova, J.; Dusinska, M.; Kuricova, M.; Soucek, P.; Vodickova, L.; Susova, S.; Naccarati, A.; Tulupova, E.; Vodicka, P. Relationship between the capacity to repair 8-oxoguanine biomarkers of genotoxicity and individual susceptibility in styreneexposed Wolkers. Mutat. Res. 2007, 634, 101-111.
89. Zhang, X.H.; Zhang, X.; Zhang, L.; Chen, Q.; Yang, Z.; Yu, J.; Fu, H.; Zhu, Y.M. XRCC1 Arg399Gln was associated with repair capacity for DNA damage induced by occupational chromium exposure. BMC Res. Notes 2012, 5, 263.
90. Qiao, Y.; Spitz, M.R.; Guo, Z.; Hadeyati, M.; Grossman, L.; Kraemer, K.H.; Wei, Q. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat. Res. 2002, 509, 165-174.
91. Qiao, Y.; Spitz, M.R.; Shen, H.; Guo, Z.; Shete, S.; Hedayati, M.; Grossman, L.; Mohrenweiser, H.; Wei, Q. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002, 23, 295-299.
92. Seker, H.; Butkiewicz, D.; Bowman, E.D.; Rusin, M.; Hedayati, M.; Grossman, L.; Harris, C.C. Functional significance of XPD polymorphic variants: Attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res. 2001, 61, 7430-7434.
93. Gu, J.; Zhao, H.; Dinney, C.P.; Zhu, Y.; Leibovici, D.; Bermejo, C.E.; Grossman, H.B.; Wu, X. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin. Cancer Res. 2005, 11, 1408-1415.
94. Nohmi, T.; Kim, S.R.; Yamada, M. Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutat. Res. 2005, 591, 60-73.
95. Hill, J.W.; Evans, M.K. A novel R229Q OGG1 polymorphism results in a thermolabile enzyme that sensitizes KG-1 leukemia cells to DNA damaging agents. Cancer Detect. Prev. 2007, 31, 237-243.
96. Endres, M.; Biniszkiewicz, D.; Sobol, R.W.; Harms, C.; Ahmadi, M.; Lipski, A.; Katchanov, J.; Mergenthaler, P.; Dirnagl, U.; Wilson S.H.; et al. Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase. J. Clin. Invest. 2004, 11 3, 1711-1721.
97. An, Q.; Robins, P.; Lindahl, T.; Barnes, D.E. C→T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases. EMBO J. 2005, 24, 2205-2213.
98. Akbari, M.; Otterlei, M.; Peña-Diaz, J.; Krokan, H.E. Different organization of base excision repair of uracil in DNA in nuclei and mitochondria and selective upregulation of mitochondrial uracil-DNA glycosylase after oxidative stress. Neuroscience 2007, 145, 1201-1212.
99. Marian, C.; Tao, M.; Mason, J.B.; Goerlitz, D.S.; Nie, J.; Chanson, A.; Freudenheim, J.L.; Shields, P.G. Single nucleotide polymorphisms in uracil-processing genes, intake of one-carbon nutrients and breast cancer risk. Eur. J. Clin. Nutr. 2011, 65, 683-689.
100. Blount, B.C.; Mack, M.M.; Wehr, C.M.; MacGregor, J.T.; Hiatt, R.A.; Wang, G.; Wickramasinghe, S.N.; Everson, R.B.; Ames, B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA 1997, 94, 3290-3295.
101. Duthie, S.J.; Narayanan, S.; Brand, G.M.; Pirie, L.; Grant, G. Impact of folate deficiency on DNA stability. J. Nutr. 2002, 132, 2444S-2449S.
102. Fenech, M. Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity. Mutat. Res. 2012, 733, 21-33.
103. Ames, B.N. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat. Res. 2001, 475, 7-20.
104. Barnes, D.E.; Lindahl, T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet. 2004, 38, 445-476.
105. Gabriel, H.E.; Crott, J.W.; Ghandour, H.; Dallal, G.E.; Choi, S.W.; Keyes, M.K.; Jang, H.; Liu, Z.; Nadeau, M.; Johnston, A.; et al. Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am. J. Clin. Nutr. 2006, 83, 835-841.
106. Ho, L.; van Leeuwen, R.; Witteman, J.C.; van Duijn, C.M.; Uitterlinden, A.G.; Hofman, A.; de Jong, P.T.; Vingerling, J.R.; Klaver, C.C. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: The Rotterdam study. Arc. Ophthalmol. 2011, 129, 758-766.
107. Christen, W.G.; Glynn, R.J.; Chew, E.Y.; Albert, C.M.; Manson, J.E. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: The Women's Antioxidant and Folic Acid Cardiovascular Study. Arch. Intern. Med. 2009, 169, 335-341.